From order to infusion: The time-sensitive journey of a radiopharmaceutical treatment
For radiopharmaceuticals, timing isn’t just important — it’s everything
In one location, a carefully prepared cancer therapy is combined with a radioactive isotope and calibrated to deliver a precise amount of radioactivity. In another, a treatment team readies a room, reviews timing, and prepares for a patient’s arrival. Somewhere in between, specialists are watching the clock, the route, the temperature, the paperwork, and every handoff.
This is a unique class of medicinal products that contain radioactive isotopes used primarily for diagnostic imaging and therapy in nuclear medicine. Their short radioactive half-life means they may decay within a few days, so staying on schedule is critical.
What may feel like a single appointment for a patient is often the final step in a global effort designed to deliver the right therapy at the right time. The following patient journey demonstrates the extraordinary care and precision that delivering these therapies requires in the real world.
New hope for Domingo
When Domingo gets the call, he’s standing in his kitchen with his wife.
His first treatment has been confirmed for later that week. After months of appointments, scans, and conversations about advanced prostate cancer, he’s reached another important milestone. A radiopharmaceutical treatment has been designed to target his cancer cells with precision. If things go well, he’ll undergo multiple treatment cycles, but for now, this first step is all that matters to his family.
Domingo thanks the nurse, hangs up, and looks across the room at his wife. He doesn’t say much at first. He doesn’t need to. They both understand what this moment means.
It means a plan is in motion. For Domingo, the first treatment day will feel calm if all goes well. That calm is born of precision behind the scenes, and this is how it unfolds.
Confirming the order
Once Domingo’s physician confirms he’s ready for treatment, the process begins with the order itself.
This isn’t a routine shipment request. The distributor needs to know what product is being moved, its shelf-life, the isotope involved, how it must be packaged, the temperature range required, and where and when it must arrive. They also need to confirm whether the treatment is moving domestically or across borders, as well as what regulatory requirements apply in every location it will pass through.
For a therapy like Domingo’s, the schedule is built backward from the infusion chair. The treatment center has a fixed administration window. Clinical staff are scheduled. The patient is scheduled. The shipment plan must align with all of it.
That’s why the first step is about more than placing an order. It’s about verifying that every detail needed for safe, timely execution is in place before the treatment begins its journey.
Planning around the dose, not the distance
In ordinary shipping, the fastest route is often the best route. In radiopharmaceutical logistics, the best route is the one most likely to protect the treatment window.
At Cencora, our radiopharmaceutical teams plan each movement around shelf-life, half-life, airport cutoffs, local handling rules, and treatment-site timing. The optimal route is mapped out, and alternate routes may be prepared in case challenges arise. Customs requirements are reviewed early. Contingency plans are built before the shipment ever leaves the point of origin.
This is especially important in a global environment, where countries can apply international standards differently. A shipment moving through Europe, North America, or Asia-Pacific may encounter different requirements for driver training, radiation oversight, storage in transit, airport handling, or documentation review. Even when global guidance exists, local execution can vary. Our extensive local presence around the world is invaluable in keeping things moving smoothly.
For Domingo, that complexity remains invisible. He only knows his treatment has been scheduled for Friday morning. But somewhere else, specialists are already planning around that exact moment.
Preparing the dose with precision
Radiopharmaceutical treatments are different from traditional medicines because time changes the product itself. Radioactive decay begins immediately after the radioisotope has been manufactured. The dose must be prepared so that it delivers the required amount of radioactivity at the intended date and time of administration.
That means calibration is critical.
If the dose arrives too late, it will be ruined. If preparation timing is off, the treatment window can be compromised before transport even begins. Manufacturing, transport, and treatment can’t be treated as separate events; they’re one connected process.
By the time Domingo receives a reminder call from the clinic, the therapy intended for him is already in motion.
Packaging for safety and product integrity
Domingo’s shipment can’t travel in standard packaging. Radiopharmaceuticals require packaging that addresses two realities at once: radiation safety and pharmaceutical protection.
Radioactive materials need a special package designed to provide shielding and withstand transport conditions. At the same time, the product may need temperature control to help preserve quality. This combination creates a highly specialized packaging challenge.
Radiopharma shipment packaging involves a shielding lead pot containing the radiopharmaceutical inside a stable, certified transport box. Either this packaging or an additional overpack provides the temperature-controlled solution, which is tested in controlled environments before use.
When it comes to packaging and transporting a radiopharma treatment, precision and safety are absolutely paramount.
Certified teams take custody
When the shipment is handed off, expertise matters as much as speed. Not every courier, facility, or airport team is authorized and prepared to handle radioactive materials. Radiopharmaceutical movements require trained personnel, documented chain of custody, and processes aligned with both pharmaceutical quality expectations and Dangerous Goods Class 7 requirements.
That level of training isn’t a simple, one-time event either. It involves ongoing certification, standardized procedures, and clear rules about who is authorized to handle these shipments.
Cencora’s radiopharma capabilities are designed around that reality, with certified staff, standardized operating procedures, and a global network spanning more than 120 company-owned facilities in more than 50 countries. Each handoff is a potential point of risk, so reducing variation can help reduce delays and protect the treatment schedule.
Domingo may think of his treatment as a moment between him and his care team, but it’s actually a coordinated effort involving countless specialists he will never meet.
Navigating borders, airports, and approvals
For a radiopharmaceutical shipment like Domingo’s, distance is only part of the challenge.
His dose may face airline restrictions, airport handling limitations, or customs requirements that differ by country. Some countries require shipment registration in national portals and/or national licenses for transport of radioactive materials. Others require specific driver qualifications, a radiation protection plan for the company that includes radiation safety advisers, radiation measurements, or special permissions for in-transit storage. Even when the shipment complies with global standards, local implementation can affect how smoothly it moves.
That’s when Cencora’s customs consultation and pre-clearance support can play an important role. Errors don’t just create paperwork problems; they can threaten the treatment window. Successfully moving therapies across international borders requires preparation, persistence, and deep familiarity with international regulations and local requirements.
Domingo won’t hear about any of this unless something goes wrong. The goal is that he never has to.
Protecting the treatment window with real-time visibility
In our approach to modern radiopharma logistics, visibility isn’t just informational — it’s operational. Domingo’s shipment is in transit, and the work doesn’t stop until it reaches him safely.
Our teams monitor milestones, track location, watch timing, and prepare to respond if conditions change. In some solutions, real-time location monitoring and temperature visibility can support proactive intervention. Control tower teams may escalate issues quickly if a flight is delayed, a cutoff is at risk, or an unexpected disruption threatens the route.
If a shipment is delayed, teams may need to make decisions immediately. Can it still make the dosing window? Should the route change? Does customs need additional support? Cencora’s real-time monitoring helps answer those questions before a small issue becomes a missed treatment.
For Domingo, what he experiences is certainty. His appointment remains on the calendar. The clinic confirms everything is on track.
Preparing the treatment site for Domingo’s arrival
As Domingo’s dose moves closer, the treatment center is preparing, too.
Radiopharmaceutical care isn’t only about getting the product to the right address. It’s also about getting it to a site that is ready to receive, verify, and administer it according to schedule. The nuclear medicine unit, pharmacy, and clinical team all have roles to play. Timing, staffing, and patient readiness must line up with the shipment’s arrival.
The coordination services Cencora provides are especially important, because patients are referred to specialized sites for radiopharmaceutical treatment with a nuclear pharmacy and a nuclear medicine site. Their primary oncologist or urologist may not administer the therapy directly. That adds another layer to the patient’s appointment, and it’s another reason why reliable coordination is essential.
Domingo and his wife leave early on treatment day. Traffic is lighter than expected. He looks out the window and tries not to think too far ahead, but he feels a spark of hope grow brighter inside of himself.
At the clinic, the team is ready thanks to all the planning and careful execution that came before Domingo’s visit.
Treating Domingo
When Domingo sits down for treatment, the global journey comes down to a single, life-changing moment.
Cencora’s packaging, route planning, certifications, customs checks, monitoring tools, and contingency plans all give way to something more personal: a nurse explaining the next step, a clinician answering his questions, his wife waiting nearby.
For Domingo, the treatment isn’t a supply chain event; it’s a chance to keep moving forward.
The journey behind the hope
On paper, radiopharmaceuticals can seem defined by complexity — half-lives, radioactive materials, narrow dosing windows, and international regulations. But their purpose is simple. They’re meant to reach a patient in time to offer renewed hope against cancer.
Domingo’s story is fictional, but the journey it reflects is real for many patients receiving radiopharmaceutical therapies around the world.
In radiopharma, reaching patients means connecting manufacturing, packaging, trained handling, cross-border expertise, real-time visibility, and clinical coordination into a single, time-sensitive chain.
For Cencora’s radiopharmaceutical teams, it also means taking extra precautions at every step, because every step affects the next. For the patient, it means something beautifully simple:
The therapy made it. The team was ready. Hope moved forward.
Before Domingo’s story began
Patients like Domingo need to focus their attention on healing, not whether their treatment will be delivered safely. For the team behind the therapy, transportation is just one piece of the puzzle, and it helps to have a partner who can help you see the big picture.
With years of experience in pharmaceutical commercialization, Cencora can support your commercialization journey from start to finish with tested solutions including:
- Clinical development
- Clinical trials
- Market access strategy
- Regulatory affairs and CMC
- Quality management and compliance (QMC)
- Real-world evidence (RWE)
- Health economics outcomes research (HEOR)
- Channel strategy
- Market research and insights
- Patient safety (pharmacovigilance)
